Following a robust Q4 earnings beat, IBM's strategic focus on hybrid cloud, AI, and quantum computing earns a price target upgrade from Bank of America, with analysts citing improved growth and free cash flow trajectory.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
Bank of America has modestly lowered its price target on JD.com, following a similar move by DBS, as analysts revise down revenue and profit estimates for the Chinese e-commerce giant, citing weaker consumer electronics demand and scaled-back subsidy programs.
A sharp, unexpected jump in wholesale prices complicates the White House's economic narrative and its pressure campaign on the Federal Reserve for rate cuts.
Drivers across the Southeast are feeling the pinch as average pump prices in the Lower Atlantic region rose to $2.75 per gallon this week, continuing an upward trend that analysts link to seasonal demand and refinery adjustments.
Analysts at Truist reaffirm their Buy rating on DLocal (DLO), raising their price target to $17 ahead of the fintech firm's Q4 2025 earnings. While expecting solid results, they flag challenging year-over-year volume comparisons that may cap upside surprises.
Erasca Inc. (ERAS) sees its price target raised from $5 to $12 by Guggenheim, following promising clinical data for its lead oncology candidates and updated financial models. The move comes amid a series of positive analyst revisions for the clinical-stage biopharma firm.
LifeSci Capital reaffirms its Buy rating on Olema Pharmaceuticals (OLMA) and raises its price target to $45, following bullish analyst sentiment on the company's lead drug candidate, Palazestrant, for ER+/HER2- breast cancer.
Truist Securities raises its price target on Meta Platforms to $900, maintaining a Buy rating. The upgrade follows stronger-than-expected Q4 results and a robust Q1 outlook, driven by AI enhancements boosting ad performance and user engagement.
Analyst firm Compass Point reiterates its Buy rating on Invesco Mortgage Capital Inc. (IVR), increasing its price target to $9.50, citing attractive mortgage spreads as a key catalyst for the REIT's potential book value growth.
U.S. producer prices rose more than anticipated in December, driven primarily by increasing costs in the services sector. The data suggests businesses are beginning to pass on tariff-related expenses to consumers, potentially signaling a reacceleration of inflationary pressures.
As industry analysts warn of a critical NAND wafer shortage in 2026-2027, SanDisk's stock soars. Jim Cramer highlights the memory maker's positioning, with Mizuho and Benchmark raising price targets significantly on expectations of a 330% price spike.
Drivers across the Midwest are feeling the pinch as average gasoline prices rose for a second consecutive week, with regional costs now sitting significantly below the national average.
RBC Capital has reaffirmed its confidence in Ascendis Pharma, raising its price target following the company's ambitious 2026 strategic goals, which hinge on sustained momentum for its lead therapy and significant long-term revenue targets.
Vera Therapeutics (VERA) is drawing bullish attention from Wall Street, with multiple analysts significantly raising price targets following a key competitor's FDA approval and revised revenue forecasts for its lead drug candidate.
Shares of Meta Platforms soared Thursday, fueled by a significant price target upgrade from BofA Securities. The rally comes despite the company reporting a slight dip in full-year profit, as investors focus on strong revenue growth and the company's positioning in the artificial intelligence race.
Fueled by a return-to-office push and AI sector optimism, San Francisco rents are climbing at their fastest rate in over a decade, starkly contrasting with cooling prices in Los Angeles.
A recent adjustment to Ceres Power Holdings' price target by analysts signals a broader reassessment of the clean energy firm's market narrative and future trajectory, moving beyond a single figure to underlying story shifts.
Revvity shares have faced significant pressure, down over 13% in the past year. A deep dive into its valuation reveals a stark contradiction: while a cash flow model suggests the stock is undervalued, its price-to-earnings multiple tells a different story. We examine the numbers and what they mean for investors.
National average gasoline prices showed minimal movement in the week ending February 2, 2026, hovering near $2.88 per gallon. However, the gap between the most and least expensive markets exceeds $2.65, highlighting ongoing regional volatility despite overall price stability.
